Atlas Wealth LLC reduced its holdings in The Procter & Gamble Company (NYSE:PG - Free Report) by 3.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 82,297 shares of the company's stock after selling 2,798 shares during the quarter. Procter & Gamble comprises 5.2% of Atlas Wealth LLC's portfolio, making the stock its 5th biggest holding. Atlas Wealth LLC's holdings in Procter & Gamble were worth $13,797,000 at the end of the most recent quarter.
Other large investors have also made changes to their positions in the company. NewSquare Capital LLC grew its position in Procter & Gamble by 933.3% during the fourth quarter. NewSquare Capital LLC now owns 155 shares of the company's stock worth $26,000 after buying an additional 140 shares in the last quarter. RPg Family Wealth Advisory LLC acquired a new position in Procter & Gamble in the 3rd quarter valued at approximately $33,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Procter & Gamble during the 4th quarter worth approximately $34,000. Atlantic Private Wealth LLC increased its position in shares of Procter & Gamble by 95.3% during the fourth quarter. Atlantic Private Wealth LLC now owns 207 shares of the company's stock valued at $35,000 after purchasing an additional 101 shares during the period. Finally, Noble Wealth Management PBC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at $39,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Analyst Upgrades and Downgrades
A number of research firms have weighed in on PG. UBS Group reiterated a "buy" rating on shares of Procter & Gamble in a research note on Monday, February 10th. JPMorgan Chase & Co. lowered their target price on shares of Procter & Gamble from $186.00 to $181.00 and set an "overweight" rating on the stock in a research note on Thursday, January 16th. Erste Group Bank upgraded shares of Procter & Gamble from a "hold" rating to a "strong-buy" rating in a research note on Monday, March 17th. Wells Fargo & Company upped their price objective on Procter & Gamble from $176.00 to $180.00 and gave the company an "overweight" rating in a research note on Thursday, January 23rd. Finally, Piper Sandler cut their target price on Procter & Gamble from $173.00 to $172.00 and set a "neutral" rating for the company in a research report on Monday, February 24th. Seven equities research analysts have rated the stock with a hold rating, twelve have issued a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $181.47.
Get Our Latest Analysis on Procter & Gamble
Insider Activity
In related news, CEO Gary A. Coombe sold 18,000 shares of the firm's stock in a transaction on Tuesday, February 25th. The stock was sold at an average price of $171.66, for a total transaction of $3,089,880.00. Following the sale, the chief executive officer now owns 22,051 shares of the company's stock, valued at approximately $3,785,274.66. This trade represents a 44.94 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Marc S. Pritchard sold 90,450 shares of the business's stock in a transaction dated Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total value of $14,819,328.00. Following the completion of the transaction, the insider now directly owns 172,814 shares of the company's stock, valued at approximately $28,313,845.76. The trade was a 34.36 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 143,450 shares of company stock valued at $23,988,008 in the last ninety days. 0.18% of the stock is owned by insiders.
Procter & Gamble Trading Down 0.6 %
Procter & Gamble stock traded down $0.96 during trading hours on Monday, reaching $165.73. 6,101,316 shares of the company's stock traded hands, compared to its average volume of 6,478,573. The Procter & Gamble Company has a fifty-two week low of $153.52 and a fifty-two week high of $180.43. The firm's 50 day moving average is $168.11 and its 200-day moving average is $169.58. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.76. The firm has a market capitalization of $388.61 billion, a price-to-earnings ratio of 26.39, a PEG ratio of 3.76 and a beta of 0.41.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Wednesday, January 22nd. The company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 18.35% and a return on equity of 33.00%. The firm had revenue of $21.88 billion during the quarter, compared to analyst estimates of $21.66 billion. During the same quarter in the previous year, the business earned $1.84 EPS. The business's quarterly revenue was up 2.1% compared to the same quarter last year. On average, analysts predict that The Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Stockholders of record on Friday, January 24th were given a dividend of $1.0065 per share. The ex-dividend date was Friday, January 24th. This represents a $4.03 annualized dividend and a dividend yield of 2.43%. Procter & Gamble's payout ratio is currently 64.01%.
Procter & Gamble Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also

Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.